pandem
demonstr
need
accur
conveni
approach
diagnos
therapeut
monitor
respiratori
viral
infect
demonstr
sampl
foam
swab
welltoler
provid
quantit
viral
output
concord
flock
swab
use
longitudin
homebas
selfsampl
demonstr
nasal
cytokin
level
correl
cluster
accord
immun
cell
origin
period
stabl
viral
load
follow
rapid
elimin
could
coupl
cytokin
expans
contract
use
mathemat
model
nasal
foam
swab
selfsampl
home
provid
precis
mechanist
readout
respiratori
viru
shed
local
immun
respons
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
critic
research
prioriti
develop
rapid
molecular
test
provid
accur
diagnosi
determin
infecti
transmiss
allow
monitor
viral
load
therapi
numer
viral
infect
includ
influenza
viral
load
correl
diseas
sever
secondari
household
attack
rate
earli
studi
suggest
peak
viral
load
differenti
mild
sever
furthermor
viral
load
monitor
antivir
therapi
mainstay
variou
human
infect
includ
hiv
hepat
b
cytomegaloviru
hepat
c
infect
particularli
virus
sever
clinic
outcom
occur
minor
patient
viral
load
may
serv
use
surrog
marker
design
smaller
still
suffici
power
treatment
studi
individu
current
licens
flock
swab
may
optim
patient
vulner
mucos
membran
low
platelet
count
eg
follow
cytotox
chemotherapi
associ
discomfort
possibl
bleed
moreov
gener
level
discomfort
may
deter
particip
collect
longitudin
sampl
may
limit
widespread
use
selftest
especi
surveil
test
use
vulner
patient
children
importantli
reliabl
comfort
homebas
selftest
methodolog
need
prevent
potenti
infect
individu
enter
healthcar
facil
test
transmit
viru
healthcar
worker
patient
initi
data
foam
swab
promis
suggest
broader
role
homebas
selfswab
respiratori
viral
pandem
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
instruct
easi
follow
agre
strongli
agre
collect
kit
return
process
easi
serial
homebas
test
appear
wellaccept
methodolog
steadyst
nasal
passag
viral
load
kinet
respiratori
viru
infect
longitudin
sampl
portion
studi
abl
detect
virus
includ
seven
human
rhinoviru
hrv
two
coronaviru
cov
one
bocaviru
bov
two
adenoviru
adv
one
human
metapneumoviru
mpv
one
respiratori
syncyti
viru
rsv
case
four
instanc
viral
coinfect
though
case
domin
viru
evid
base
greater
durat
shed
higher
viral
load
fig
durat
shed
heterogen
case
hrv
shed
last
week
one
instanc
shed
one
short
singleday
blip
rsv
mpv
episod
prolong
adv
bov
cov
shed
shortliv
though
one
case
level
adv
shed
evid
throughout
sampl
period
fig
extend
period
hrv
rsv
hmpv
shed
viral
load
remark
stabl
sampl
sampl
fig
hrv
gener
pattern
viral
load
steadi
state
slight
gradual
declin
follow
rapid
elimin
note
singl
case
rsv
similar
profil
initi
high
viral
load
peak
shorter
durat
shed
singl
case
mpv
protract
declin
singl
reexpans
phase
transient
observ
period
steadi
state
viral
load
highli
unlik
occur
chanc
true
viral
load
fluctuat
exhibit
stochast
nois
thu
sampl
method
appear
highli
reliabl
data
also
suggest
brief
period
equilibrium
viru
local
immun
system
viral
elimin
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
viral
load
kinet
predictor
respiratori
viru
symptom
gener
level
symptom
appear
track
detect
viru
particularli
cov
hrv
mpv
singl
case
rsv
high
number
symptom
persist
beyond
viral
elimin
fig
hrv
infect
greater
one
day
durat
shed
correl
strongli
durat
symptom
hrv
infect
individu
symptom
subsid
immedi
concurr
soon
viral
elimin
low
viral
load
infect
last
day
associ
smaller
number
symptom
prolong
higher
viral
load
episod
fig
stabl
surg
nasal
cytokin
level
respiratori
viru
infect
next
follow
level
differ
cytokin
infect
measur
specimen
viral
load
measur
sever
cytokin
particularli
nondefin
pathway
eotaxin
notabl
stabil
within
studi
particip
independ
viral
shed
fig
supp
fig
interferon
also
rel
invari
across
within
person
result
demonstr
consist
swab
techniqu
yield
molecul
impact
presenc
viral
infect
valid
precis
approach
molecul
particularli
associ
cytotox
cell
respons
granzym
b
perforin
macrophag
respons
show
monoton
expans
clearanc
respons
infect
particularli
dynam
shift
exampl
rsv
hpmv
one
instanc
hrv
highest
initi
viral
load
fig
supp
fig
cytokin
dynam
particip
monoton
expans
clearanc
respons
infect
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
cytokin
correl
accord
cellular
origin
next
examin
six
particip
hrv
infect
correl
cytokin
pattern
infer
cellular
origin
exampl
high
posit
correl
note
among
analyt
associ
cytotox
cell
respons
granzym
b
perforin
among
sever
macrophag
epitheli
cell
deriv
cytokin
among
cluster
associ
respons
associ
cytokin
also
correl
mani
cytolyt
cell
macrophag
associ
cytokin
fig
hrv
viral
load
moder
correl
number
paramet
particularli
granzym
b
perforin
protein
induc
result
suggest
hrv
may
induc
intens
local
molecular
immun
respons
dosedepend
fashion
similar
result
occur
inclus
sampl
particip
cohort
supp
fig
next
examin
cytokin
correl
person
infect
inflammatori
respiratori
virus
rsv
mpv
note
similar
correl
trend
data
hrv
correl
among
relat
pair
granzym
b
perforin
tnfalpha
higher
rsv
mpv
hrv
fig
cytokin
pair
tempor
kinet
often
strikingli
similar
suggest
equival
cellular
sourc
fig
supp
fig
also
overal
lack
correl
cytokin
associ
cell
respons
associ
epitheli
cell
macrophag
viral
load
correl
mani
cytokin
cell
origin
fig
suggest
rsv
mpv
may
induc
inflamm
dosedepend
fashion
sampl
cluster
accord
degre
inflamm
next
sort
hrv
sampl
use
linkag
cluster
analysi
approach
demonstr
three
class
sampl
distinguish
level
mani
tcell
macrophageassoci
molecular
immun
factor
fig
minor
sampl
blue
class
highest
level
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
granzym
b
perforin
high
viral
load
sampl
two
particip
six
particip
sampl
least
inflammatori
class
grey
particip
sampl
moder
inflammatori
class
green
data
indic
inflammatori
immun
milieu
hrvinfect
nasal
passag
dynam
time
tilt
toward
higher
inflamm
higher
viral
load
similar
result
observ
sampl
analyz
though
two
class
sampl
distinguish
supp
fig
case
virus
inflammatori
cytokin
cluster
clearli
associ
high
viral
load
rsv
mpv
fig
mathemat
model
perform
mathemat
model
separ
data
particip
infect
rsv
examin
whether
complex
immun
viral
data
sampl
could
coupl
mechanist
first
develop
ordinari
differenti
equat
model
equat
link
rsv
viral
load
earli
late
immun
respons
evalu
cytokin
may
track
respons
earli
immun
respons
found
log
concentr
chang
posit
correl
viral
load
first
day
enrol
supp
fig
evalu
model
two
cytokin
track
rsvearli
immun
respons
late
immun
respons
evalu
model
fit
observ
cytokin
supp
fig
equival
approach
carri
forward
model
mpv
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
fig
show
result
model
schemat
differenti
equat
captur
rate
chang
suscept
cell
infect
cell
viral
load
fig
two
cytokin
fig
best
fit
achiev
model
assum
concentr
depend
kill
first
earli
stage
infect
mediat
elimin
infect
cell
mechan
satur
amount
possibl
kill
certain
level
model
suggest
rsv
earli
surg
lead
slight
rise
per
cell
kill
rate
infect
cell
fig
lead
mass
elimin
infect
cell
rate
million
cell
per
day
decreas
viral
load
factor
howev
respons
clear
viru
steadi
state
viral
load
persist
day
mediat
respons
appear
respons
kill
far
rapidli
intens
respons
togeth
respons
remov
remain
infect
cell
day
onset
symptom
fig
model
fit
use
data
provid
earli
clearanc
rather
result
wors
fit
data
supp
fig
late
result
allow
best
fit
cytokin
less
success
suggest
two
molecul
may
play
major
role
rsv
control
vivo
rule
effect
cytokin
effector
molecul
limit
infect
next
fit
model
data
particip
infect
mpv
found
model
abl
recapitul
viral
load
project
similar
kill
pattern
earli
late
immun
respons
rsv
model
supp
fig
demonstr
home
selfsampl
nasal
foam
swab
welltoler
provid
reliabl
result
monitor
viral
load
well
molecular
immun
respons
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
respiratori
viru
infect
result
enorm
practic
implic
selfcollect
home
safe
noninvas
easili
learn
allow
reliabl
method
diagnosi
well
therapeut
monitor
kit
could
easili
use
home
drive
test
environ
provid
avenu
elimin
contact
infect
contagi
person
health
care
provid
could
also
use
hospit
clinic
set
therebi
save
personnel
time
person
protect
equip
use
comfort
safe
afford
foam
swab
also
highlight
possibl
scale
approach
pediatr
adult
elderli
immunocompromis
popul
current
pandem
futur
deadli
respiratori
viru
epidem
home
selfswab
vital
tool
addit
anatom
site
also
consid
increas
yield
current
fda
recommend
suggest
use
midturbin
nasal
swab
oropharyng
swab
maxim
yield
absenc
nasopharyng
swab
prior
data
demonstr
selfcollect
throat
swab
addit
selfcollect
foam
nasal
swab
increas
yield
significantli
respiratori
virus
suggest
addit
oral
swab
may
need
especi
set
swab
shortag
selfcollect
foam
swab
use
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
longitudin
studi
solid
organ
transplant
recipi
good
complianc
particip
report
issu
swab
discomfort
specif
swab
use
prior
studi
present
studi
custom
design
limit
discomfort
maintain
adequ
sensit
demonstr
stabil
swab
without
transport
media
storag
room
temperatur
day
make
ideal
home
selftest
follow
shipment
directli
test
lab
furthermor
shown
highli
stabl
surfac
make
home
foam
swab
feasibl
attract
option
pathogen
also
demonstr
abil
accur
sampl
local
cytokin
present
picogram
level
use
foam
swab
viral
measur
made
combin
precis
virolog
immunolog
readout
local
infect
highli
relev
develop
clinic
sever
score
biomark
studi
begin
show
viral
load
may
predict
sever
equal
plausibl
intens
phenotyp
earli
local
cellular
immun
respons
play
causal
role
limit
extent
infect
follow
molecular
immun
respons
close
daili
sampl
interv
also
provid
adequ
data
mathemat
model
link
specif
arm
cellular
immun
respons
pathogen
control
real
time
goal
difficult
attain
major
viral
infect
human
studi
demonstr
sever
novel
featur
respiratori
viru
kinet
rsv
infect
achiev
brief
extrem
high
viral
load
follow
steadi
state
final
rapid
phase
elimin
hrv
also
remark
stabl
viral
load
particip
rapidli
elimin
major
observ
episod
viral
shed
strongli
correl
symptom
viral
load
decreas
symptom
tend
dissip
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
follow
complet
sampl
collect
particip
ask
complet
brief
survey
assess
toler
accept
test
method
sampl
process
conic
vial
contain
swab
vortex
buffer
remov
store
pcr
analysi
swab
remov
conic
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
vial
place
prechil
spinx
filter
handl
swab
remov
buffer
remain
conic
vial
transfer
spinx
filter
contain
swab
spinx
filter
spun
minut
brake
fresh
cytokin
preserv
buffer
ad
spinx
filter
incub
wet
ice
minut
spun
minut
brake
swab
filter
discard
filter
buffer
aliquot
increment
store
test
plate
wash
respect
detect
antibodi
mixtur
ad
well
plate
incub
shake
hour
plate
wash
read
buffer
ad
well
plate
read
msd
plate
reader
meso
quickplex
sq
protein
concentr
determin
use
msd
discoveri
workbench
analysi
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
softwar
light
intens
sampl
interpol
use
fourparamet
logist
fit
standard
curv
electrochemiluminesc
gener
known
concentr
standard
lower
limit
detect
marker
found
manufactur
websit
http
wwwmesoscalecommediafileshandoutsassaylistpdf
statist
analysi
foam
versu
flock
swab
studi
pcr
result
posit
qualit
assay
limit
detect
imput
copi
per
ml
use
limit
detect
divid
two
pcr
result
neg
result
assign
valu
concord
correl
coeffici
ccc
use
measur
agreement
quantit
result
pair
sampl
foam
versu
flock
swab
left
versu
right
nostril
sampl
sum
versu
maximum
valu
left
right
nostril
longitudin
sampl
studi
cytokin
result
fit
curv
rang
assign
valu
lower
limit
detect
divid
two
result
fit
curv
rang
assign
valu
upper
limit
detect
result
analysi
symptom
repres
total
number
symptom
present
day
total
supp
tabl
clear
rate
final
free
viru
produc
rate
clear
rate
model
express
schemat
fig
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
variabl
g
tri
model
fit
cytokin
variabl
c
individu
select
surrog
acquir
immun
respons
rsv
c
cytokin
gave
lower
sum
squar
error
model
fit
model
fit
model
fit
perform
fit
model
equat
data
assum
time
enrol
also
assum
initi
concentr
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
supplement
figur
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
supplement
figur
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
supplement
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
